{"podcast":{"title":"Auckland News Today | 2 Min News | The Daily News Now!","slug":"auckland-news-today-2-min-news-the-daily-news-now-7853371","podcast_index_feed_id":7853371,"rss_url":"https://feeds.fastcast.ai/auckland-news-today-2-min-news-the-daily-news-now.xml","website_url":null,"image_url":"https://image.fastcast.ai/cover/0c68619e-caff-4b32-b0e4-3fe6ef0c4e17.png","author":"The Daily News Now!","episode_count":666,"summary":"Hosted by Corey with the Story. Auckland News Today delivers fast, focused updates on the stories shaping New Zealand’s largest city—covering local government, business, housing, transport, culture, and more. Stay informed with quick, reliable daily briefings designed for listeners on the go. From breaking headlines to the developments that matter most, this is your daily snapshot of Auckland. Produced by AI as part of The Daily News Now network. Advertise with us: advertise@thednn.ai","last_synced_at":"2026-09-18T06:19:36.974852+00:00","page_url":"https://stenobird.com/podcast/auckland-news-today-2-min-news-the-daily-news-now-7853371"},"episode":{"title":"New ADHD Med Launches October","slug":"new-adhd-med-launches-october","published_at":"2026-06-24T00:06:08+00:00","page_url":"https://stenobird.com/podcast/auckland-news-today-2-min-news-the-daily-news-now-7853371/new-adhd-med-launches-october","show_page_url":"https://stenobird.com/podcast/auckland-news-today-2-min-news-the-daily-news-now-7853371","url":"https://api.fastcast.ai/audio/4c0c4af8-97a3-431f-93e0-fb365e3d34e0.mp3","audio_url":"https://api.fastcast.ai/audio/4c0c4af8-97a3-431f-93e0-fb365e3d34e0.mp3","summary":"Big news for ADHD patients in New Zealand: Pharmac is launching Rubifen LA, a new long-acting methylphenidate starting October 1st, to boost supply and expand treatment options. With strengths including a new 60mg dose, it joins seven other brands now available — helping ease ongoing shortages that’ve plagued the country since 2023. Originally slated for July, the delay gives suppliers more time, while also covering narcolepsy patients under existing practice. This move responds directly to patient stress and disruption, offering more stability and choice for those relying on these meds until at least 2026. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/6d1531719dfdb5f9","meta_description":"Big news for ADHD patients in New Zealand: Pharmac is launching Rubifen LA, a new long-acting methylphenidate starting October 1st, to boost supply and ex…","key_points":[],"chapters":[],"topics":[],"duration_seconds":111,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/auckland-news-today-2-min-news-the-daily-news-now-7853371/episodes/new-adhd-med-launches-october/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/auckland-news-today-2-min-news-the-daily-news-now-7853371/new-adhd-med-launches-october.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}